Staar Surgical Co (FRA:SR3) Cyclically Adjusted PB Ratio: (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SR3 Staar Surgical Co FRA:SR3
81 GF Score
Price €21.50
GF Value €27.43
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Staar Surgical Co  (FRA:SR3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Staar Surgical Co Cyclically Adjusted PB Ratio Related Terms


Staar Surgical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co Cyclically Adjusted PB Ratio Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.37 16.84 8.66 5.52 4.54

Staar Surgical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.51 5.42 4.54 3.51 0.00

FRA:SR3 vs KMTS, AZTA, BLFS: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Cyclically Adjusted PB Ratio falls into.


FRA:SR3
81GF Score
Staar Surgical Co FRA:SR3
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Staar Surgical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Staar Surgical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.158/333.9520*333.9520
=6.158

Current CPI (Jun. 2026) = 333.9520.

Staar Surgical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.828 241.428 1.145
201612 0.882 241.432 1.220
201703 0.845 243.801 1.157
201706 0.829 244.955 1.130
201709 0.829 246.819 1.122
201712 0.877 246.524 1.188
201803 0.895 249.554 1.198
201806 1.044 251.989 1.384
201809 2.504 252.439 3.313
201812 2.634 251.233 3.501
201903 2.735 254.202 3.593
201906 2.868 256.143 3.739
201909 3.040 256.759 3.954
201912 3.210 256.974 4.172
202003 3.310 258.115 4.283
202006 3.388 257.797 4.389
202009 3.435 260.280 4.407
202012 3.490 260.474 4.475
202103 3.840 264.877 4.841
202106 4.109 271.696 5.051
202109 4.448 274.310 5.415
202112 4.796 278.802 5.745
202203 5.248 287.504 6.096
202206 5.896 296.311 6.645
202209 6.708 296.808 7.547
202212 6.581 296.797 7.405
202303 6.550 301.836 7.247
202306 6.731 305.109 7.367
202309 7.267 307.789 7.885
202312 7.247 306.746 7.890
202403 7.399 312.332 7.911
202406 7.731 314.175 8.218
202409 7.829 315.301 8.292
202412 7.698 315.605 8.146
202503 6.537 319.799 6.826
202506 5.890 322.561 6.098
202509 6.107 324.800 6.279
202512 5.950 324.054 6.132
202603 6.123 330.213 6.192
202606 6.158 333.952 6.158

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Staar Surgical Co (FRA:SR3) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of €21.50 is trading 21.6% below its estimated GF Value™ of €27.43. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for FRA:SR3:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €27.43 vs. price of €21.50 (21.6% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:SR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staar Surgical Co Business Description

Other Exchanges STAA:USA
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
81GF Score

Get the complete analysis for FRA:SR3

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.50
Price
€27.43
GF Value